1. Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy. Issue 13 (16th June 2021) Authors: Iluta, Sabina; Pasca, Sergiu; Gafencu, Grigore; Jurj, Ancuta; Terec, Andreea; Teodorescu, Patric; Selicean, Cristina; Jitaru, Ciprian; Preda, Alexandra; Cenariu, Diana; Constantinescu, Catalin; Iordache, Maria; Tigu, Bogdan; Munteanu, Raluca; Feder, Richard; Dima, Delia; Zdrenghea, Mihnea; Gulei,... Journal: Journal of cellular and molecular medicine Issue: Volume 25:Issue 13(2021) Page Start: 6094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MECOM, HBS1L‐MYB, THRB‐RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients. Issue 1 (10th November 2017) Authors: Trifa, Adrian P.; Bănescu, Claudia; Bojan, Anca S.; Voina, Cristian M.; Popa, Ștefana; Vișan, Simona; Ciubean, Alina D.; Tripon, Florin; Dima, Delia; Popov, Viola M.; Vesa, Ștefan C.; Andreescu, Mihaela; Török‐Vistai, Tünde; Mihăilă, Romeo G.; Berbec, Nicoleta; Macarie, Ioan; Coliţă, Andrei; Iord... Journal: American journal of hematology Issue: Volume 93:Issue 1(2018:Jan.) Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗